Literature DB >> 27643871

Return to normal life after hematopoietic stem cell transplantation for thalassemia: a study of patients transplanted from matched sibling donors.

G Caocci1,2, A Vacca2, E Piras2, V Serreli2, C Dessi3, M Marcias3, P Risso4, G La Nasa1,2.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27643871     DOI： 10.1038/bmt.2016.243

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  11 in total

1.  The problem of quality of life in medicine.

Authors:  A Leplège; S Hunt
Journal:  JAMA       Date:  1997-07-02       Impact factor: 56.272

2.  Prospective assessment of health-related quality of life in pediatric patients with beta-thalassemia following hematopoietic stem cell transplantation.

Authors:  Giovanni Caocci; Fabio Efficace; Francesca Ciotti; Maria Grazia Roncarolo; Adriana Vacca; Eugenia Piras; Roberto Littera; Raji Suleiman Dawood Markous; Gary Stephen Collins; Fabio Ciceri; Franco Mandelli; Sarah Marktel; Giorgio La Nasa
Journal:  Biol Blood Marrow Transplant       Date:  2010-09-24       Impact factor: 5.742

Review 3.  Conditioning regimens in allo-SCT for thalassemia major.

Authors:  V Mathews; B N Savani
Journal:  Bone Marrow Transplant       Date:  2014-01-20       Impact factor: 5.483

4.  Long-term health-related quality of life evaluated more than 20 years after hematopoietic stem cell transplantation for thalassemia.

Authors:  Giorgio La Nasa; Giovanni Caocci; Fabio Efficace; Carlo Dessì; Adriana Vacca; Eugenia Piras; Marco Sanna; Michela Marcias; Roberto Littera; Carlo Carcassi; Guido Lucarelli
Journal:  Blood       Date:  2013-08-19       Impact factor: 22.113

Review 5.  Hematopoietic stem cell transplantation for thalassemia.

Authors:  Javid Gaziev; Guido Lucarelli
Journal:  Curr Stem Cell Res Ther       Date:  2011-06       Impact factor: 3.828

6.  Quality of life assessment in hematopoietic stem cell transplantation performed on thalassemia major patients.

Authors:  Vedat Uygun; Funda Tayfun; Mediha Akcan; Gulsun Tezcan Karasu; Alphan Kupesiz; Volkan Hazar; Akif Yeşilipek
Journal:  Pediatr Hematol Oncol       Date:  2012-06-19       Impact factor: 1.969

7.  Quality of life in patients with transfusion-dependent thalassemia after hematopoietic SCT.

Authors:  D K L Cheuk; A S P Mok; A C W Lee; A K S Chiang; S Y Ha; Y L Lau; G C F Chan
Journal:  Bone Marrow Transplant       Date:  2008-06-16       Impact factor: 5.483

8.  Long-term results of survival in patients with thalassemia major treated with bone marrow transplantation.

Authors:  Paolo Di Bartolomeo; Stella Santarone; Erminia Di Bartolomeo; Paola Olioso; Pasqua Bavaro; Gabriele Papalinetti; Paolo Di Carlo; Franco Papola; Antonio Nicolucci; Marta Di Nicola; Antonio Iacone
Journal:  Am J Hematol       Date:  2008-07       Impact factor: 10.047

9.  Status of donor-recipient HLA class I ligands and not the KIR genotype is predictive for the outcome of unrelated hematopoietic stem cell transplantation in beta-thalassemia patients.

Authors:  Giorgio La Nasa; Roberto Littera; Franco Locatelli; Claudio Giardini; Arianna Ventrella; Marina Mulargia; Adriana Vacca; Nicola Orrù; Sandro Orrù; Eugenia Piras; Giada Giustolisi; Daniela Lisini; Sonia Nesci; Giovanni Caocci; Carlo Carcassi
Journal:  Biol Blood Marrow Transplant       Date:  2007-09-14       Impact factor: 5.742

10.  Comparison of Blood Transfusion Plus Chelation Therapy and Bone Marrow Transplantation in Patients with β-Thalassemia: Application of SF-36, EQ-5D, and Visual Analogue Scale Measures.

Authors:  Mehdi Javanbakht; Ali Keshtkaran; Hossien Shabaninejad; Hassan Karami; Maryam Zakerinia; Sajad Delavari
Journal:  Int J Health Policy Manag       Date:  2015-06-13
View more
  3 in total

1.  A systematic review of quality of life in sickle cell disease and thalassemia after stem cell transplant or gene therapy.

Authors:  Sherif M Badawy; Usman Beg; Robert I Liem; Sonali Chaudhury; Alexis A Thompson
Journal:  Blood Adv       Date:  2021-01-26

2.  Hematopoietic stem cell transplantation for thalassemia major using HLA fully-matched and mismatched donor grafts.

Authors:  Chuwen Huang; Yuhua Qu; Sha Liu; Shushan Nie; Hua Jiang
Journal:  Transl Pediatr       Date:  2021-06

3.  Economic evaluation of betibeglogene autotemcel (Beti-cel) gene addition therapy in transfusion-dependent β-thalassemia.

Authors:  Anuraag R Kansal; Odette S Reifsnider; Sarah B Brand; Neil Hawkins; Anna Coughlan; Shujun Li; Lael Cragin; Clark Paramore; Andrew C Dietz; J Jaime Caro
Journal:  J Mark Access Health Policy       Date:  2021-06-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.